The Health Care Blog noted some new analysis and numbers about drug firms writing major articles on behalf of clinicians – articles that continue to make their way into major peer reviewed journals. David Healy is quoted. Industry Veteran fumes about THCB’s seeming moderation on the issue.
Labels: bad behavior, big pharma, blogging, ghost writing
